Research status and prospect of remyelination in multiple sclerosis based on "inflammation-tissue" homeostatic coupling.
- Author:
Li-Na YANG
1
;
Xin-Ke DU
1
;
Li LIU
1
;
Man-Jing LI
1
;
Qing-Sen RAN
1
;
Qing YANG
1
;
Li-Dong SUN
1
;
Yu-Jie LI
1
;
Ying CHEN
1
;
Xiao-Xin ZHU
1
;
Qi LI
1
Author Information
- Publication Type:Journal Article
- Keywords: inflammatory homeostasis; microglia; multiple sclerosis; remyelination; tissue homeostasis
- MeSH: Humans; Multiple Sclerosis/pathology*; Remyelination/physiology*; Myelin Sheath/pathology*; Inflammation/drug therapy*; Homeostasis
- From: China Journal of Chinese Materia Medica 2023;48(1):5-12
- CountryChina
- Language:Chinese
- Abstract: Multiple sclerosis(MS) shows the pathological characteristics of "inflammatory injury of white matter" and "myelin repair disability" in the central nervous system(CNS). It is very essential for MS treatment and reduction of disease burden to strengthen repair, improve function, and reduce disability. Accordingly, different from the simple immunosuppression, we believe that key to strengthening remyelination and maintaining the "damage-repair" homeostasis of tissue is to change the current one-way immunosuppression strategy and achieve the "moderate pro-inflammation-effective inflammation removal" homeostasis. Traditional Chinese medicine shows huge potential in this strategy. Through literature research, this study summarized the research on remyelination, discussed the "mode-rate pro-inflammation-effective inflammation removal" homeostasis and the "damage-repair" homeostasis based on microglia, and summed up the key links in remyelination in MS. This review is expected to lay a theoretical basis for improving the function of MS patients and guide the application of traditional Chinese medicine.
